Joel E. Bernstein serves as Executive at Winston Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Joel E. Bernstein has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 19, 2010 involved purchasing 18,399,271 shares valued at $0.
Joel E. Bernstein currently holds 18,399,271 shares of Winston Pharmaceuticals, Inc. (WPHM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joel E. Bernstein has been a net neutral trader of WPHM stock. They have purchased $0 and sold $0 worth of shares.
Joel E. Bernstein's most recent insider trade was on May 19, 2010, when they purchased 18,399,271 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.40 |
| Discretionary |